Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Stacie B Dusetzina

Biographic Data

ID5534236
NAMEStacie B Dusetzina
GIVEN NAMESStacie B
FAMILY NAMEDusetzina
SIGNATUREDUSETZINA S B
AFFILIATIONSUniversity of North Carolina at Chapel Hill
ORCID0000-0002-3907-9196
VERIFIEDYes
TOTAL WORKS26
TOTAL CITATIONS0
AUTHOR COUNT26
EDITOR COUNT0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Medigap Protection and Plan Switching Among Medicare Advantage Enrollees With Cancer

    Open Access•YoungMin Kwon, Shelley A Jazowski et al.•ARTICLE•JAMA Health Forum•2025

    In this cohort study, state Medigap guaranteed issue protections were associated with higher rates of switching to TM among MA beneficiaries newly diagnosed with cancer. These findings underscore the protective association of state Medigap regulations in facilitating a switch to TM (especially among beneficiaries who likely desired more flexibility in accessing and receiving care) and illuminate potential disparities in switching that may reflect…

  • Adolescent Treatment Landscape of Depression, Suicidality, and Substance Use Disorder in the US

    Open Access•Dennis Lee, Stacie B Dusetzina et al.•ARTICLE•JAMA Health Forum•2025

    The results of this cross-sectional survey study suggest that adolescents and young adults with SUDs rarely received treatment. Adolescents are especially vulnerable to treatment gaps once reaching young adulthood, and medications for opioid use disorder are systematically underused, especially for adolescents

  • Association of State Conscientious Objection Laws and Sexual Minority Population Health

    Open Access•Nathaniel M Tran, Tara Mckay et al.•ARTICLE•Sexuality Research and Social…•2025•References: 2

    Introduction The legality of denying health services based on sexual orientation is actively being litigated in the United States. Currently, ten US states have passed conscientious objection laws, allowing for denial of health services based on sexual orientation. The objective of this study was to estimate the association between state conscientious objection laws and changes in health service use and health status among sexual minority adults.…

  • Aging in isolation

    Open Access•Nathaniel M Tran, Tara Mckay et al.•ARTICLE•SSM - Population Health•2024

    We identified significant unmet need for social supports for IADL impairments, with highest unmet need among SM women. Comprehensive strategies such as LGBTQ + affirming assisted living and home and community-based services are needed to ensure equity in receipt of long-term supports and services for SM populations

  • High Deductible Health Plans and Use of Free Preventive Services Under the Affordable Care Act

    Open Access•Paul Shafer, Stacie B Dusetzina et al.•ARTICLE•INQUIRY The Journal of Health…•2023

    The Affordable Care Act aimed to increase use of preventive services by eliminating cost-sharing to consumers. However, patients may be unaware of this benefit or they may not seek preventive services if they anticipate that the cost of potential diagnostic or treatment services will be too high, both more likely among those in high deductible health plans. We used nationally representative private health insurance claims (100% sample of IBM ® Ma…

  • Avenues for Strengthening PCORnet’s Capacity to Advance Patient-Centered Economic Outcomes in Patient-Centered Outcomes Research (PCOR)

    Open Access•Lemuel R Waitman, Leonard Charles Bailey et al.•ARTICLE•Medical Care•2023•References: 30

    PCORnet, the National Patient-Centered Clinical Research Network, provides the ability to conduct prospective and observational pragmatic research by leveraging standardized, curated electronic health records data together with patient and stakeholder engagement. PCORnet is funded by the Patient-Centered Outcomes Research Institute (PCORI) and is composed of 8 Clinical Research Networks that incorporate at total of 79 health system “sites.” As th…

  • Cost-Sharing Reform for Chronic Disease Treatments as a Strategy to Improve Health Care Equity and Value in the US

    Open Access•Utibe R Essien, Jay B Lusk et al.•ARTICLE•JAMA Health Forum•2022

    This Viewpoint discusses cost-sharing reform for chronic disease treatments as a strategy to improve patient outcomes, promote health equity, and minimize long-term health care expenditures in the US

  • Reforming Reimbursement for the US Food and Drug Administration’s Accelerated Approval Program to Support State Medicaid Programs

    Open Access•Rachel E Sachs, Julie M Donohue et al.•ARTICLE•JAMA Health Forum•2022

    Policy makers may wish to consider options for reforming reimbursement for accelerated approval products in addition to reforms to the FDA's operation of the pathway. Policy reform proposals can provide a range of options to evaluate trade-offs of access and pricing

  • Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use

    Open Access•Samantha G Auty, Paul R Shafer et al.•ARTICLE•JAMA Health Forum•2021

    In this cross-sectional study of data from 39 states and the District of Columbia, carve outs of direct-acting antiviral HCV medications from Medicaid MCO prescription drug coverage were associated with significant increases in HCV medication use. Given their clinical benefits, greater uptake of HCV medication may help improve the health of Medicaid enrollees with HCV and reduce the economic burden of untreated HCV on the US health care system

  • Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps

    Open Access•Stacie B Dusetzina, Haiden A Huskamp et al.•ARTICLE•JAMA Health Forum•2021

    In this cohort study, among states adopting oncology parity laws between 2013 and 2017, mean out-of-pocket spending per OAM prescription fill and mean health plan spending among OAM users was similar in states with and without caps. However, enrollees in states with parity plus out-of-pocket caps had greater reductions in out-of-pocket spending among the highest spenders. Caps may offer improved financial protection for the highest spenders witho…

  • Drug Pricing Reform in 2021—Going Big or Going Bipartisan

    Open Access•Stacie B Dusetzina, Michelle M Mello•ARTICLE•JAMA Health Forum•2021

  • Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval

    Open Access•Rachel E Sachs, Kyle A Gavulic et al.•ARTICLE•JAMA Health Forum•2021

    In this cross-sectional study of 216 drugs granted accelerated approval, state spending on drugs approved through the FDA's growing accelerated approval program represented an outsized amount of spending relative to use. Because drugs with accelerated approval have come to market on the basis of trials using surrogate end points, considerable amounts of this spending may have been attributable to products with unproven clinical benefits

  • Peer Comparisons for Drug Price Setting

    Open Access•Kyle A Gavulic, Nathalie Pelletier-Fleury et al.•ARTICLE•JAMA Health Forum•2020

  • Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV

    Nadya Belenky, Brian W Pence et al.•ARTICLE•AIDS Care•2019

    Depression is common among women with HIV and untreated depression can result in poor quality of life and worsen HIV outcomes. Women with HIV who are dually enrolled in Medicaid and Medicare faced a potential disruption in medication access when Medicare Part D was implemented in 2006. The goal of this study was to estimate the effects of Medicare Part D implementation on antidepressant use, depressive symptoms, and hospitalization in Medicaid-Me…

  • Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients

    Jennifer C Spencer, Noel T Brewer et al.•ARTICLE•American Journal of Public Health•2018•References: 21

    Objectives. To assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series. Methods. Using MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated the bivalent or quadrivalent HPV vaccine series from 2006 to 2014, with follow-up data extending through 2015. The study outcome was receipt of third H…

  • Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders

    Greta A Bushnell, Greta Bushnell et al.•ARTICLE•Medical Care•2018•References: 49

    BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacotherapy for pediatric anxiety disorders but adherence remains difficult to predict. OBJECTIVES: To estimate SSRI adherence in children with anxiety disorders and determine if prior parental medication adherence is predictive of child high SSRI adherence. METHODS: We identified children (3-17 y) initiating SSRI treatment after an anxiety disorder dia…

  • Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and Adap Use in Dual Eligibles With HIV

    Nadya Belenky, Brian W Pence et al.•ARTICLE•Medical Care•2018•References: 15

    BACKGROUND: The implementation of Medicare part D on January 1, 2006 required all adults who were dually enrolled in Medicaid and Medicare (dual eligibles) to transition prescription drug coverage from Medicaid to Medicare part D. Changes in payment systems and utilization management along with the loss of Medicaid protections had the potential to disrupt medication access, with uncertain consequences for dual eligibles with human immunodeficienc…

  • The effect of a celebrity health disclosure on demand for health care

    Open Access•Megan C Roberts, Stacie B Dusetzina•ARTICLE•Journal of Community Genetics•2017

  • Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods

    Lydia E Pace, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2016•References: 26

    BACKGROUND: The Affordable Care Act (ACA) required most private insurance plans to cover contraceptive services without patient cost-sharing as of January 2013 for most plans. Whether the ACA's mandate has impacted long-acting reversible contraceptives (LARC) use is unknown. OBJECTIVE: The aim of this article is to assess trends in LARC cost-sharing and uptake before and one year after implementation of the ACA's contraceptive mandate. DESIGN: A …

  • Mental Health Service Use for Adult Patients With Co-occurring Depression and Physical Chronic Health Care Needs, 2007–2010

    Mónica Pérez Jolles, Lindsey Haynes-Maslow et al.•ARTICLE•Medical Care•2015•References: 23

    BACKGROUND: Individuals with mental illness experience poor health and may die prematurely from chronic illness. Understanding whether the presence of co-occurring chronic physical health conditions complicates mental health treatment is important, particularly among patients seeking treatment in primary care settings. OBJECTIVES: Examine (1) whether the presence of chronic physical conditions is associated with mental health service use for indi…

  • High-Risk Medication Use by Nursing Home Residents Before and After Hospitalization

    David G Stevenson, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2014•References: 16

    BACKGROUND: Two prominent challenges in nursing home care are ensuring appropriate medication use and achieving high-quality care as residents transition from the hospital to the nursing home. Research about prescribing practices at this important clinical juncture is limited. OBJECTIVE: To analyze the use of high-risk medications by nursing home residents before and after being hospitalized. We define high-risk medications using the Beers criter…

  • Cost of Contraceptive Methods to Privately Insured Women in the United States

    Open Access•Stacie B Dusetzina, Vanessa K Dalton et al.•ARTICLE•Women s Health Issues•2013

  • Medicare Part D Plan Generosity and Medication Use Among Dual-eligible Nursing Home Residents

    Haiden A Huskamp, David G Stevenson et al.•ARTICLE•Medical Care•2013•References: 4

    BACKGROUND: In 2006, dual-eligible nursing home residents were randomly assigned to a Medicare Part D prescription drug plan (PDP). Subsequently, residents not enrolled in qualified plans at the start of the next year were rerandomized. PDPs vary in generosity through differences in medication coverage and utilization management. Therefore, residents' assigned plans may be relatively more or less generous for their particular drugs. The impact of…

  • The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance

    Lydia E Pace, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2013•References: 8

    BACKGROUND: Long-acting reversible contraception (LARC) is highly effective but also has higher initiation costs than oral contraceptive methods, which may contribute to relatively low use. The Affordable Care Act requires most private insurance plans to cover contraceptive services without patient cost-sharing. Whether this mandate will increase LARC use is unknown. OBJECTIVE: To assess the relationship between cost-sharing and use of LARC among…

  • The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered Drugs

    Rena M Conti, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2013•References: 4

    BACKGROUND: Spending on physician-administered drugs is high and uses not approved by the US Food and Drug Administration (FDA) are frequent. Although these drugs may be targets of future policy efforts to rationalize use, little is known regarding how physicians respond to emerging safety and effectiveness evidence. STUDY OBJECTIVE: We analyzed changes in bevacizumab (Avastin) use for breast cancer in response to its market launch (February 2008…

Next

No prominent works on this page.

  • Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors

    Stacie B Dusetzina, Ashley S Higashi et al.•ARTICLE•Medical Care•2012•References: 51

    OBJECTIVE: To review literature on the impact of The Food and Drug Administration (FDA) drug risk communications on medication utilization, health care services use, and health outcomes. DATA SOURCES: The authors searched MEDLINE and the Web of Science for manuscripts published between January 1990 and November 2010 that included terms related to drug utilization, the FDA, and advisories or warnings. We manually searched bibliographies and works …

  • Cost of Contraceptive Methods to Privately Insured Women in the United States

    Open Access•Stacie B Dusetzina, Vanessa K Dalton et al.•ARTICLE•Women s Health Issues•2013

  • Medicare Part D Plan Generosity and Medication Use Among Dual-eligible Nursing Home Residents

    Haiden A Huskamp, David G Stevenson et al.•ARTICLE•Medical Care•2013•References: 4

    BACKGROUND: In 2006, dual-eligible nursing home residents were randomly assigned to a Medicare Part D prescription drug plan (PDP). Subsequently, residents not enrolled in qualified plans at the start of the next year were rerandomized. PDPs vary in generosity through differences in medication coverage and utilization management. Therefore, residents' assigned plans may be relatively more or less generous for their particular drugs. The impact of…

  • The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance

    Lydia E Pace, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2013•References: 8

    BACKGROUND: Long-acting reversible contraception (LARC) is highly effective but also has higher initiation costs than oral contraceptive methods, which may contribute to relatively low use. The Affordable Care Act requires most private insurance plans to cover contraceptive services without patient cost-sharing. Whether this mandate will increase LARC use is unknown. OBJECTIVE: To assess the relationship between cost-sharing and use of LARC among…

  • The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered Drugs

    Rena M Conti, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2013•References: 4

    BACKGROUND: Spending on physician-administered drugs is high and uses not approved by the US Food and Drug Administration (FDA) are frequent. Although these drugs may be targets of future policy efforts to rationalize use, little is known regarding how physicians respond to emerging safety and effectiveness evidence. STUDY OBJECTIVE: We analyzed changes in bevacizumab (Avastin) use for breast cancer in response to its market launch (February 2008…

  • High-Risk Medication Use by Nursing Home Residents Before and After Hospitalization

    David G Stevenson, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2014•References: 16

    BACKGROUND: Two prominent challenges in nursing home care are ensuring appropriate medication use and achieving high-quality care as residents transition from the hospital to the nursing home. Research about prescribing practices at this important clinical juncture is limited. OBJECTIVE: To analyze the use of high-risk medications by nursing home residents before and after being hospitalized. We define high-risk medications using the Beers criter…

  • Mental Health Service Use for Adult Patients With Co-occurring Depression and Physical Chronic Health Care Needs, 2007–2010

    Mónica Pérez Jolles, Lindsey Haynes-Maslow et al.•ARTICLE•Medical Care•2015•References: 23

    BACKGROUND: Individuals with mental illness experience poor health and may die prematurely from chronic illness. Understanding whether the presence of co-occurring chronic physical health conditions complicates mental health treatment is important, particularly among patients seeking treatment in primary care settings. OBJECTIVES: Examine (1) whether the presence of chronic physical conditions is associated with mental health service use for indi…

  • Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods

    Lydia E Pace, Stacie B Dusetzina et al.•ARTICLE•Medical Care•2016•References: 26

    BACKGROUND: The Affordable Care Act (ACA) required most private insurance plans to cover contraceptive services without patient cost-sharing as of January 2013 for most plans. Whether the ACA's mandate has impacted long-acting reversible contraceptives (LARC) use is unknown. OBJECTIVE: The aim of this article is to assess trends in LARC cost-sharing and uptake before and one year after implementation of the ACA's contraceptive mandate. DESIGN: A …

  • The effect of a celebrity health disclosure on demand for health care

    Open Access•Megan C Roberts, Stacie B Dusetzina•ARTICLE•Journal of Community Genetics•2017

  • Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients

    Jennifer C Spencer, Noel T Brewer et al.•ARTICLE•American Journal of Public Health•2018•References: 21

    Objectives. To assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series. Methods. Using MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated the bivalent or quadrivalent HPV vaccine series from 2006 to 2014, with follow-up data extending through 2015. The study outcome was receipt of third H…

  • Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders

    Greta A Bushnell, Greta Bushnell et al.•ARTICLE•Medical Care•2018•References: 49

    BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacotherapy for pediatric anxiety disorders but adherence remains difficult to predict. OBJECTIVES: To estimate SSRI adherence in children with anxiety disorders and determine if prior parental medication adherence is predictive of child high SSRI adherence. METHODS: We identified children (3-17 y) initiating SSRI treatment after an anxiety disorder dia…

  • Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and Adap Use in Dual Eligibles With HIV

    Nadya Belenky, Brian W Pence et al.•ARTICLE•Medical Care•2018•References: 15

    BACKGROUND: The implementation of Medicare part D on January 1, 2006 required all adults who were dually enrolled in Medicaid and Medicare (dual eligibles) to transition prescription drug coverage from Medicaid to Medicare part D. Changes in payment systems and utilization management along with the loss of Medicaid protections had the potential to disrupt medication access, with uncertain consequences for dual eligibles with human immunodeficienc…

  • Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV

    Nadya Belenky, Brian W Pence et al.•ARTICLE•AIDS Care•2019

    Depression is common among women with HIV and untreated depression can result in poor quality of life and worsen HIV outcomes. Women with HIV who are dually enrolled in Medicaid and Medicare faced a potential disruption in medication access when Medicare Part D was implemented in 2006. The goal of this study was to estimate the effects of Medicare Part D implementation on antidepressant use, depressive symptoms, and hospitalization in Medicaid-Me…

  • Peer Comparisons for Drug Price Setting

    Open Access•Kyle A Gavulic, Nathalie Pelletier-Fleury et al.•ARTICLE•JAMA Health Forum•2020

  • Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use

    Open Access•Samantha G Auty, Paul R Shafer et al.•ARTICLE•JAMA Health Forum•2021

    In this cross-sectional study of data from 39 states and the District of Columbia, carve outs of direct-acting antiviral HCV medications from Medicaid MCO prescription drug coverage were associated with significant increases in HCV medication use. Given their clinical benefits, greater uptake of HCV medication may help improve the health of Medicaid enrollees with HCV and reduce the economic burden of untreated HCV on the US health care system

  • Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps

    Open Access•Stacie B Dusetzina, Haiden A Huskamp et al.•ARTICLE•JAMA Health Forum•2021

    In this cohort study, among states adopting oncology parity laws between 2013 and 2017, mean out-of-pocket spending per OAM prescription fill and mean health plan spending among OAM users was similar in states with and without caps. However, enrollees in states with parity plus out-of-pocket caps had greater reductions in out-of-pocket spending among the highest spenders. Caps may offer improved financial protection for the highest spenders witho…

  • Drug Pricing Reform in 2021—Going Big or Going Bipartisan

    Open Access•Stacie B Dusetzina, Michelle M Mello•ARTICLE•JAMA Health Forum•2021

  • Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval

    Open Access•Rachel E Sachs, Kyle A Gavulic et al.•ARTICLE•JAMA Health Forum•2021

    In this cross-sectional study of 216 drugs granted accelerated approval, state spending on drugs approved through the FDA's growing accelerated approval program represented an outsized amount of spending relative to use. Because drugs with accelerated approval have come to market on the basis of trials using surrogate end points, considerable amounts of this spending may have been attributable to products with unproven clinical benefits

  • Cost-Sharing Reform for Chronic Disease Treatments as a Strategy to Improve Health Care Equity and Value in the US

    Open Access•Utibe R Essien, Jay B Lusk et al.•ARTICLE•JAMA Health Forum•2022

    This Viewpoint discusses cost-sharing reform for chronic disease treatments as a strategy to improve patient outcomes, promote health equity, and minimize long-term health care expenditures in the US

  • Reforming Reimbursement for the US Food and Drug Administration’s Accelerated Approval Program to Support State Medicaid Programs

    Open Access•Rachel E Sachs, Julie M Donohue et al.•ARTICLE•JAMA Health Forum•2022

    Policy makers may wish to consider options for reforming reimbursement for accelerated approval products in addition to reforms to the FDA's operation of the pathway. Policy reform proposals can provide a range of options to evaluate trade-offs of access and pricing

  • High Deductible Health Plans and Use of Free Preventive Services Under the Affordable Care Act

    Open Access•Paul Shafer, Stacie B Dusetzina et al.•ARTICLE•INQUIRY The Journal of Health…•2023

    The Affordable Care Act aimed to increase use of preventive services by eliminating cost-sharing to consumers. However, patients may be unaware of this benefit or they may not seek preventive services if they anticipate that the cost of potential diagnostic or treatment services will be too high, both more likely among those in high deductible health plans. We used nationally representative private health insurance claims (100% sample of IBM ® Ma…

  • Avenues for Strengthening PCORnet’s Capacity to Advance Patient-Centered Economic Outcomes in Patient-Centered Outcomes Research (PCOR)

    Open Access•Lemuel R Waitman, Leonard Charles Bailey et al.•ARTICLE•Medical Care•2023•References: 30

    PCORnet, the National Patient-Centered Clinical Research Network, provides the ability to conduct prospective and observational pragmatic research by leveraging standardized, curated electronic health records data together with patient and stakeholder engagement. PCORnet is funded by the Patient-Centered Outcomes Research Institute (PCORI) and is composed of 8 Clinical Research Networks that incorporate at total of 79 health system “sites.” As th…

  • Aging in isolation

    Open Access•Nathaniel M Tran, Tara Mckay et al.•ARTICLE•SSM - Population Health•2024

    We identified significant unmet need for social supports for IADL impairments, with highest unmet need among SM women. Comprehensive strategies such as LGBTQ + affirming assisted living and home and community-based services are needed to ensure equity in receipt of long-term supports and services for SM populations

  • Medigap Protection and Plan Switching Among Medicare Advantage Enrollees With Cancer

    Open Access•YoungMin Kwon, Shelley A Jazowski et al.•ARTICLE•JAMA Health Forum•2025

    In this cohort study, state Medigap guaranteed issue protections were associated with higher rates of switching to TM among MA beneficiaries newly diagnosed with cancer. These findings underscore the protective association of state Medigap regulations in facilitating a switch to TM (especially among beneficiaries who likely desired more flexibility in accessing and receiving care) and illuminate potential disparities in switching that may reflect…

  • Adolescent Treatment Landscape of Depression, Suicidality, and Substance Use Disorder in the US

    Open Access•Dennis Lee, Stacie B Dusetzina et al.•ARTICLE•JAMA Health Forum•2025

    The results of this cross-sectional survey study suggest that adolescents and young adults with SUDs rarely received treatment. Adolescents are especially vulnerable to treatment gaps once reaching young adulthood, and medications for opioid use disorder are systematically underused, especially for adolescents

Medicine (24 works) · Family medicine (16 works) · Health care (16 works) · Health Systems, Economic Evaluations, Quality of Life (10 works) · Nursing (10 works) · Population (9 works) · Environmental health (8 works) · Internal Medicine (7 works) · Business (6 works) · Demography (6 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae